Riva, M., Crucitti, L., Ravano, E., Nichelatti, M., Reda, G., Fiamenghi, C., et al. (2018). Danazol Treatment for Thrombocytopenia in Lower-Risk Myelodysplastic Syndromes: A Pilot Real Life Experience. Intervento presentato a: 60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018, San Diego, CA [10.1182/blood-2018-99-115283].

Danazol Treatment for Thrombocytopenia in Lower-Risk Myelodysplastic Syndromes: A Pilot Real Life Experience

Cairoli R;
2018

paper
hematology
English
60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018
2018
2018
132
S1
4375
none
Riva, M., Crucitti, L., Ravano, E., Nichelatti, M., Reda, G., Fiamenghi, C., et al. (2018). Danazol Treatment for Thrombocytopenia in Lower-Risk Myelodysplastic Syndromes: A Pilot Real Life Experience. Intervento presentato a: 60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018, San Diego, CA [10.1182/blood-2018-99-115283].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/409422
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
Social impact